Total Parenteral Nutrition-Associated Liver Disease
NCT00031135 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2015-03-25
Summary
This is a study to determine whether choline, when added to total parenteral nutrition (TPN), can help prevent the development of hepatic steatosis, a liver disease, in patients on TPN.
Conditions
Interventions
- DRUG
-
Choline Chloride
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
Eligibility
- Min Age
- 21 Years
- Max Age
- 74 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-09-30
- Completion
- 2005-09-30
Countries
- United States
Study Locations
More Related Trials
-
Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in Infants
NCT00004410 ·Status: COMPLETED ·Phase: NA
-
Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants
NCT01062815 ·Status: TERMINATED ·Phase: NA
-
Prospective Randomized Clinical Trial of Intravenous Lipids and Cholestasis
NCT01555957 ·Status: COMPLETED ·Phase: PHASE3
-
Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders
NCT01373918 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis
NCT00826020 ·Status: COMPLETED ·Phase: PHASE2
-
Cholic Acid for Hepatic Steatosis in Lipodystrophy
NCT00457639 ·Status: COMPLETED ·Phase: PHASE2
-
Dietary Supplementation With Butyrate in Individuals With Liver Steatosis and Metabolic Syndrome
NCT06398522 ·Status: COMPLETED ·Phase: NA
-
Cholestasis Prevention: Efficacy of IV Fish Oil
NCT00512629 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support
NCT06910943 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury
NCT02010034 ·Status: COMPLETED ·Phase: NA
-
Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants
NCT02420496 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase Deficiency
NCT00006061 ·Status: COMPLETED ·Phase: NA
-
The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients
NCT01974336 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Omega 3 Oil Emulsion for Parenteral Nutrition Associated Cholestasis
NCT02148146 ·Status: NO_LONGER_AVAILABLE
-
Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver Disease
NCT01739517 ·Status: UNKNOWN ·Phase: PHASE2
-
Compassionate Use of Omegaven to Reverse Parenteral Nutrition Induced Cholestasis
NCT01173159 ·Status: COMPLETED ·Phase: NA
-
Omegaven® as Parenteral Nutrition
NCT02334293 ·Status: UNKNOWN ·Phase: NA
-
Study of Bile Acids in Patients With Peroxisomal Disorders
NCT00004442 ·Status: TERMINATED ·Phase: NA
-
Effects of Carnitine Supplementation on Liver and Muscle
NCT03439917 ·Status: COMPLETED ·Phase: NA
-
Impact Of Choline in Patients With NAFLD
NCT05200156 ·Status: UNKNOWN ·Phase: NA
-
Lipid Emulsions and Liver Function - Results After 5 Years.
NCT04347902 ·Status: COMPLETED ·Phase: PHASE4
-
Cholestasis Reversal: Efficacy of IV Fish Oil
NCT00910104 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Parenteral Lipid Emulsions and the Liver Function
NCT03044639 ·Status: COMPLETED ·Phase: PHASE4
-
Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Associated Hepatic Injury
NCT01412359 ·Status: APPROVED_FOR_MARKETING
-
Therapy for Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder
NCT01872351 ·Status: WITHDRAWN